UCL spin-out aims to smuggle antibodies across the blood-brain barrier

UCL spin-out aims to smuggle antibodies across the blood-brain barrier

A collaboration involving academia and industry is to develop new ways of delivering antibodies to the brain using molecular envelop technology developed by Nanomerics, a UCL spin-out company.

(Visited 1 times, 1 visits today)
19
Like
Save

Comments

Comments are disabled for this post.